Research [ASAP] Development and Scale-Up of an Enabling Synthetic Route to KTX-005, a Muscarinic Acetylcholine Receptor Agonist for the Potential Treatment of Schizophrenia LikeLiked Date: February 5, 2025 Less than 1 MinRead Views: 33 Organic Process Research & Development DOI: 10.1021/acs.oprd.4c00531 Source: http://dx.doi.org/10.1021/acs.oprd.4c00531 Tags:Materials Industry FacebookTwitterLinkedinWhatsAppTelegramEmail ALT-Lab-Ad-1ALT-Lab-Ad-2ALT-Lab-Ad-3ALT-Lab-Ad-4ALT-Lab-Ad-5ALT-Lab-Ad-6ALT-Lab-Ad-7ALT-Lab-Ad-8ALT-Lab-Ad-9ALT-Lab-Ad-10ALT-Lab-Ad-11ALT-Lab-Ad-12ALT-Lab-Ad-13 Recent Articles Ni@ETS-10-catalyzed carboxylation of aryl and alkyl halides with CO2 in water: a green strategy for CO2 utilization Research June 29, 2026 Dual hydrogen-buffer and interfacial spillover effects boosting bimetallic catalysts for mild-condition guaiacol hydrodeoxygenation Research June 29, 2026 NASA’s Newest Wind Tunnel Builds on Legacy of Innovation Research June 29, 2026 Towards qualification and quantification of repairability in residential electrical energy systems: The case study of LivingLab NRW Research June 29, 2026 Decoding the effect of SO2 on CO2 capture: A combined Ab initio molecular dynamics and spectroscopic approach Research June 29, 2026 Climate School Alumni Aim for Sustainability Goals in the 2026 World Cup and Beyond Environmental News June 29, 2026 Science & AI: Stop Asking Which AI Is Smartest. Ask Which One Is Allowed to Touch Your Data. Carbon Markets June 29, 2026 Supreme Court Rules FIFRA Preempts Failure to Warn Food & Agriculture June 29, 2026 International Paper announces shutdowns, layoffs at 4 US facilities Packaging June 29, 2026 NASA Astronaut Chris Williams Preps for Spacewalk Research June 29, 2026 Load more
